These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 191387)

  • 1. Herpesvirus type 2-induced tumour-specific antigen (AG-4) and specific antibody in patients with cervical cancer and controls.
    Aurelian L; Cornish JD; Smith MF
    IARC Sci Publ (1971); 1975; (11 Pt 2):79-87. PubMed ID: 191387
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequency of antibody to a virus-induced tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls.
    Kawana T; Cornish JD; Smith MF; Aurelian L
    Cancer Res; 1976 Jun; 36(6):1910-4. PubMed ID: 1268845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
    Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
    Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to Herpesvirus hominis in patients with carcinoma of the cervix.
    Najem SN; Barton IG; Al-Omar LS; Potter CW
    Br J Exp Pathol; 1982 Oct; 63(5):485-9. PubMed ID: 6293526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of HSV-2-induced early antigen with antibodies from cervical carcinoma patients].
    Jiang JW
    Zhonghua Fu Chan Ke Za Zhi; 1986 Mar; 21(2):107-9, 126. PubMed ID: 3017644
    [No Abstract]   [Full Text] [Related]  

  • 6. Variations of cytotoxic antibodies to cells with herpes simplex virus antigens in women with progressing or regressing cancerous lesions of the cervix.
    Thiry L; Sprecher-Goldberger S; Fassin Y; Gould I; Gompel C; Pestiau J; De Halleux F
    Am J Epidemiol; 1974 Oct; 100(4):251-61. PubMed ID: 4370721
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of herpes simplex type 2 antibody status in groups of patients with cervical neoplasia in Czechoslovakia.
    Janda Z; Kanka J; Vonka V; Svoboda B
    Int J Cancer; 1973 Nov; 12(3):626-30. PubMed ID: 4364794
    [No Abstract]   [Full Text] [Related]  

  • 8. Class-specific herpes simplex virus antibodies in sera and cervical secretions from patients with cervical neoplasia: a multi-group comparison.
    Dale GE; Coleman RM; Best JM; Benetato BB; Drew NC; Chinn S; Papacosta AO; Nahmias AJ
    Epidemiol Infect; 1988 Jun; 100(3):445-65. PubMed ID: 2837405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 10. An analysis of seroepidemiological studies of herpesvirus type 2 and carcinoma of the cervix.
    Rawls WE; Adam E; Melnick JL
    Cancer Res; 1973 Jun; 33(6):1477-82. PubMed ID: 4352385
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of antibodies against herpes simplex and adenovirus in oral and cervical cancer patients--a preliminary report.
    Kumari TV; Shanmugam J; Prabha B; Vasudevan DM
    Indian J Med Res; 1982 Apr; 75():590-2. PubMed ID: 6286474
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serological aspects of the relation between herpes virus and cervico-uterine cancer].
    Suárez M; Del Campo G; Ojeda JM
    Rev Chil Obstet Ginecol; 1983; 48(1):11-5. PubMed ID: 6099904
    [No Abstract]   [Full Text] [Related]  

  • 13. IgM antibody to a tumor-associated antigen (AG-4) induced by herpes simplex virus type 2: its use in location of the antigen in infected cells.
    Aurelian L; Smith MF; Cornish DJ
    J Natl Cancer Inst; 1976 Mar; 56(3):471-7. PubMed ID: 176392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls.
    Feorino PM; Palmer EL
    J Infect Dis; 1973 Jun; 127(6):732-5. PubMed ID: 4350521
    [No Abstract]   [Full Text] [Related]  

  • 15. Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia.
    McDonald AD; Williams MC; Manfreda J; West R
    Am J Epidemiol; 1974 Aug; 100(2):130-5. PubMed ID: 4368955
    [No Abstract]   [Full Text] [Related]  

  • 16. IgG-, IgA- and IgM-antibodies to herpes simplex virus type 2 in sera from patients with cancer of the uterine cervix.
    El Falaky IH; Vestergaard BF
    Eur J Cancer (1965); 1977 Mar; 13(3):247-51. PubMed ID: 193693
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigens of carcinoma of the cervix uteri. A study by means of immunofluorescence.
    Nelson DS
    Clin Exp Immunol; 1974 Jan; 16(1):53-62. PubMed ID: 4619779
    [No Abstract]   [Full Text] [Related]  

  • 18. Herpes type-2 virus antibody status in groups of patients with neoplasm in Ibadan.
    Adelusi B; Osunkoya BO; Fabiyi A
    Afr J Med Med Sci; 1976 Dec; 5(4):297-301. PubMed ID: 204178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls.
    Pacsa AS; Kummerländer L; Pejtsik B; Pali K
    J Natl Cancer Inst; 1975 Oct; 55(4):775-81. PubMed ID: 171424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus type 2 and carcinoma of cervix uteri.
    Vardthananusara C; Wasi C; Usavajindawatn C; Thongchareon P
    J Med Assoc Thai; 1978 Jan; 61(1):14-9. PubMed ID: 204721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.